These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15647186)

  • 1. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease.
    Pierik M; De Hertogh G; Vermeire S; Van Assche G; Van Eyken P; Joossens S; Claessens G; Vlietinck R; Rutgeerts P; Geboes K
    Gut; 2005 Feb; 54(2):223-7. PubMed ID: 15647186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
    Brand S; Staudinger T; Schnitzler F; Pfennig S; Hofbauer K; Dambacher J; Seiderer J; Tillack C; Konrad A; Crispin A; Göke B; Lohse P; Ochsenkühn T
    Inflamm Bowel Dis; 2005 Jul; 11(7):645-52. PubMed ID: 15973118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
    Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
    Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort.
    Leshinsky-Silver E; Karban A; Buzhakor E; Fridlander M; Yakir B; Eliakim R; Reif S; Shaul R; Boaz M; Lev D; Levine A
    Pediatr Res; 2005 Sep; 58(3):499-504. PubMed ID: 16148063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
    Laukens D; Peeters H; Marichal D; Vander Cruyssen B; Mielants H; Elewaut D; Demetter P; Cuvelier C; Van Den Berghe M; Rottiers P; Veys EM; Remaut E; Steidler L; De Keyser F; De Vos M
    Ann Rheum Dis; 2005 Jun; 64(6):930-5. PubMed ID: 15539413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.
    Lakatos PL; Lakatos L; Szalay F; Willheim-Polli C; Osterreicher C; Tulassay Z; Molnar T; Reinisch W; Papp J; Mozsik G; Ferenci P;
    World J Gastroenterol; 2005 Mar; 11(10):1489-95. PubMed ID: 15770725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.
    Heresbach D; Alexandre JL; Branger B; Bretagne JF; Cruchant E; Dabadie A; Dartois-Hoguin M; Girardot PM; Jouanolle H; Kerneis J; Le Verger JC; Louvain V; Politis J; Richecoeur M; Robaszkiewicz M; Seyrig JA;
    Gut; 2005 Feb; 54(2):215-22. PubMed ID: 15647184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.
    Török HP; Glas J; Tonenchi L; Mussack T; Folwaczny C
    Clin Immunol; 2004 Jul; 112(1):85-91. PubMed ID: 15207785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
    Arnott ID; Nimmo ER; Drummond HE; Fennell J; Smith BR; MacKinlay E; Morecroft J; Anderson N; Kelleher D; O'Sullivan M; McManus R; Satsangi J
    Genes Immun; 2004 Aug; 5(5):417-25. PubMed ID: 15190267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
    Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
    Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulomas in Crohn's disease: are newly discovered genetic variants involved?
    Mazor Y; Karban A; Nesher S; Weiss B; Leshinsky-Silver E; Levine A; Eliakim R
    J Crohns Colitis; 2010 Oct; 4(4):438-43. PubMed ID: 21122541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn's disease.
    Shaoul R; Karban A; Weiss B; Reif S; Wasserman D; Pacht A; Eliakim R; Wardi J; Shirin H; Wine E; Leshinsky-Silver E; Levine A
    Inflamm Bowel Dis; 2004 Nov; 10(6):709-14. PubMed ID: 15626887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.